Cytek Biosciences Inc. (CTKB)
Jiang Wenbin 🟡 adjusted position in 17.0K shares (4 derivative) of Cytek Biosciences, Inc. (CTKB) at $4.06 Filing ID: 022521
Jiang Wenbin 🟡 adjusted position in 17.0K shares (4 derivative) of Cytek Biosciences, Inc. (CTKB) at $4.06 Filing ID: 022521
🔍 Jiang Wenbin (Executive)
Company: Cytek Biosciences, Inc. (CTKB)
Report Date: 2025-08-18
Transaction Summary:
Detailed Transactions and Holdings:
Date: 2025-08-18 | Code: M | equity_swap_involved: 0 | shares_owned_after: 5,268,493.00 | transaction_form_type: 4 | Footnotes: F1
Date: 2025-08-18 | Code: F | equity_swap_involved: 0 | shares_owned_after: 5,266,847.00 | transaction_form_type: 4 | Footnotes: F2
Date: 2025-08-18 | Code: M | equity_swap_involved: 0 | shares_owned_after: 5,278,628.00 | transaction_form_type: 4 | Footnotes: F1
Date: 2025-08-18 | Code: F | equity_swap_involved: 0 | shares_owned_after: 5,275,759.00 | transaction_form_type: 4 | Footnotes: F2
Date: 2025-08-18 | Code: M | equity_swap_involved: 0 | shares_owned_after: 5,297,859.00 | transaction_form_type: 4 | Footnotes: F1
Date: 2025-08-18 | Code: F | equity_swap_involved: 0 | shares_owned_after: 5,292,477.00 | transaction_form_type: 4 | Footnotes: F2
Date: 2025-08-18 | Code: M | equity_swap_involved: 0 | shares_owned_after: 5,321,479.00 | transaction_form_type: 4 | Footnotes: F1
Date: 2025-08-18 | Code: F | equity_swap_involved: 0 | shares_owned_after: 5,314,417.00 | transaction_form_type: 4 | Footnotes: F2
Date: 2025-08-18 | Code: M | equity_swap_involved: 0 | shares_owned_after: 11,272.00 | transaction_form_type: 4 | Footnotes: F1, F3, F3
Date: 2025-08-18 | Code: M | equity_swap_involved: 0 | shares_owned_after: 74,618.00 | transaction_form_type: 4 | Footnotes: F1, F4, F4
Date: 2025-08-18 | Code: M | equity_swap_involved: 0 | shares_owned_after: 228,373.00 | transaction_form_type: 4 | Footnotes: F1, F5, F5
Date: 2025-08-18 | Code: M | equity_swap_involved: 0 | shares_owned_after: 415,701.00 | transaction_form_type: 4 | Footnotes: F1, F6, F6
Footnotes: